ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

RVNC Revance Therapeutics Inc

3,77
-0,025 (-0,66%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Revance Therapeutics Inc RVNC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,025 -0,66% 3,77 00:00:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,91 3,655 3,99 3,77 3,795
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202422:05BWRevance to Release First Quarter 2024 Financial Results on..
12.4.202414:00BWRevance to Present New DAXXIFY® Data at the American Academy..
27.3.202421:05BWRevance Reports Inducement Grants Under Nasdaq Listing Rule..
08.3.202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202423:08EDGAR2Form 8-K - Current report
05.3.202423:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04.3.202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202415:25BWRevance Announces Pricing of $100.0 Million Public Offering..
04.3.202412:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04.3.202412:37BWRevance Announces Proposed Public Offering of Common Stock
29.2.202422:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
28.2.202422:07EDGAR2Form 8-K - Current report
28.2.202422:05BWRevance Reports Fourth Quarter and Full Year 2023 Financial..
21.2.202414:01BWRevance to Release Fourth Quarter and Full Year 2023..
21.2.202414:00BWRevance to Participate in Upcoming Investor Conferences
14.2.202421:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202422:28EDGAR2Form 8-K - Current report
13.2.202415:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06.2.202422:04EDGAR2Form 8-K - Current report
02.2.202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202414:00BWRevance Receives Permanent J-Code for DAXXIFY® and Announces..
01.2.202414:00BWRevance to Participate in the Guggenheim 6th Annual..
11.1.202412:18IHMARKETNEWSWall Street Highlights: Mastercard’s Financial Rise,..
08.1.202414:01EDGAR2Form 8-K - Current report
08.1.202414:00BWRevance Provides Corporate Update, Preliminary Fourth..
03.1.202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202322:04EDGAR2Form 8-K - Current report
12.12.202311:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
14.11.202322:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
08.11.202322:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202322:09EDGAR2Form 8-K - Current report
08.11.202322:06BWRevance Reports Third Quarter 2023 Financial Results,..
08.11.202322:05BWRevance Appoints Erica Jordan as Chief Commercial Officer,..
06.11.202314:00BWRevance to Participate in Upcoming Investor Conferences
01.11.202313:00BWRevance to Release Third Quarter 2023 Financial Results on..
26.10.202314:00BWDAXXIFY® Becomes First Facial Injectable to be Named to..
24.10.202322:05EDGAR2Form SC 13D/A - General statement of acquisition of..
19.9.202315:01EDGAR2Form 8-K - Current report
19.9.202315:00BWRevance Provides Corporate Update at Investor Day
07.9.202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202322:21EDGAR2Form 144 - Report of proposed sale of securities
05.9.202323:43EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

Delayed Upgrade Clock